RDHL - Financial Reports List - RedHill Biopharma Ltd. - IntrinsicAlpha

RedHill Biopharma Ltd. RDHL

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL

$ 2.31

-3.98 %

$ 10.6 K

Market Cap

-0.01

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Annual Report	FY	10-K	2024-12-31	23.49%	-34.57%	-115.68%
Annual Report	FY	10-K	2023-12-31	-89.46%	140.37%	129.48%
Quarterly Report	Q2	8-K	2023-06-30	-90.21%	105.34%	51.87%
Quarterly Report	Q1	8-K	2023-03-31	-80.26%	393.17%	482.70%
Quarterly Report	Q4	8-K	2022-12-31	-42.01%	110.22%	51.94%
Annual Report	FY	10-K	2022-12-31	-27.94%	48.17%	47.19%
Quarterly Report	Q3	8-K	2022-09-30	-18.77%	-200.62%	59.14%
Quarterly Report	Q2	8-K	2022-06-30	-14.68%	51.02%	63.20%
Quarterly Report	Q1	8-K	2022-03-31	-11.37%	25.04%	27.07%
Quarterly Report	Q4	8-K	2021-12-31	2.84%	-0.17%	-5.03%

1